Azilsartan Medoxomil

CAS 863031-21-4 5 current recordsSmall Molecule

Who holds supplier records for Azilsartan Medoxomil? 5 organisations hold a current record for Azilsartan Medoxomil: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: China (3) and India (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Azilsartan Medoxomil: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/azilsartan-medoxomil

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    3 of the 4 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Azilsartan Medoxomil. Country is the organisation's recorded country, not necessarily the manufacturing site.

China3India1Country not recorded for 1
Need Azilsartan Medoxomil sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) used for the treatment of hypertension. It acts by selectively blocking the binding of angiotensin II to the AT1 receptor, reducing blood pressure.

Chemical identity

IUPAC name
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Canonical SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C
InChIKey
QJFSABGVXDWMIW-UHFFFAOYSA-N
Synonyms
Edarbi API, ar-14, edarbi, ipreziv, tak 491, tak-491

Therapeutic areas

CardiovascularHypertensionAngiotensin II Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Azilsartan Medoxomil?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Azilsartan Medoxomil: ALP PHARM BEIJING CO LTD, ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO LTD (China), JUBILANT BIOSYS LTD (India), Shandong Loncom Pharmaceutical Co.,ltd. (China) and Wuhan Rs Pharmaceuticals Co., Ltd (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Azilsartan Medoxomil Drug Master Files are active?

ALP PHARM BEIJING CO LTD (DMF 29818), ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO LTD (DMF 41200), JUBILANT BIOSYS LTD (DMF 29785), Shandong Loncom Pharmaceutical Co.,ltd. (DMF 43759) and Wuhan Rs Pharmaceuticals Co., Ltd (DMF 40194). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Azilsartan Medoxomil supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Azilsartan Medoxomil?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.